Skip to content

Study on Central Plasticity Mechanism of ' Control Shift ' for Facial Paralysis and Intervention Strategies

Central Plasticity Mechanism of ' Control Shift ' in Masseter Nerve Transposition for Facial Paralysis and Intervention Strategies

Status
Recruiting
Phases
Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200060956
Enrollment
Unknown
Registered
2022-06-14
Start date
2022-06-01
Completion date
Unknown
Last updated
2023-09-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Facial Paralysis

Interventions

Group C:rTMS Stimulation
Group D:Fake Stimulation
Group E:No Stimulation
Group A?B:fMRI Scanning

Sponsors

Shanghai Ninth People’s Hospital, Shanghai Jiao Tong University School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 55 Years

Inclusion criteria

Inclusion criteria: 1. Patients with unilateral complete facial paralysis; 2. Patients with central nerve end loss or difficulty in direct repair after trauma, including temporal bone fractures caused by trauma, facial paralysis caused by ear surgery, or facial paralysis caused by intracranial surgery; 3. The time of facial nerve injury is from 7 months to 14 months, and there is no action potential in the affected lateral muscle, but there is a fibrillation potential; 4. The patient's age is 18-55 years old; 5. The patient signs an informed consent form and voluntarily participates.

Exclusion criteria

Exclusion criteria: 1. Have undergone more than one surgical treatment for facial paralysis; 2. Any side of the masseter nerve dysfunction; 3. Severe heart and liver (divided into four levels of cardiac function, belonging to 3-4 levels, with ALT>1.5 times the normal value), and renal insufficiency (Cr>133 µ Mol/L) or patients with hematopoietic dysfunction, bleeding tendency, and hemorrhagic diseases; There are systemic diseases, such as leukemia, serious diabetes, hypertension, heart disease; Inability to understand surgery and high expectations; 4. A specialist checks for the presence of a tumor, and the further development of the tumor lesion or treatment of it will affect nerve repair treatment; 5. Patients with mental and neurological disorders and malignant tumors; 6. Brain abnormalities (tumors, bleeding, infarcts) found on conventional magnetic resonance imaging; 7. There are contraindications to MRI examination.

Design outcomes

Primary

MeasureTime frame
fMRI Scanning Results;

Secondary

MeasureTime frame
Smile function after facial paralysis Surgery;

Countries

China

Contacts

Public ContactHao Ma

Shanghai Ninth People’s Hospital, Shanghai Jiao Tong University School of Medicinenghai Jiao To

mhff@163.com+86 15900848779

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026